145 related articles for article (PubMed ID: 17392284)
1. The carboxyl-terminal fragment of pro-HB-EGF reverses Bcl6-mediated gene repression.
Kinugasa Y; Hieda M; Hori M; Higashiyama S
J Biol Chem; 2007 May; 282(20):14797-806. PubMed ID: 17392284
[TBL] [Abstract][Full Text] [Related]
2. BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.
Hirata Y; Ogasawara N; Sasaki M; Mizushima T; Shimura T; Mizoshita T; Mori Y; Kubota E; Wada T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
Br J Cancer; 2009 Apr; 100(8):1320-9. PubMed ID: 19337254
[TBL] [Abstract][Full Text] [Related]
3. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
Toki F; Nanba D; Matsuura N; Higashiyama S
J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
[TBL] [Abstract][Full Text] [Related]
4. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
5. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane.
Hieda M; Isokane M; Koizumi M; Higashi C; Tachibana T; Shudou M; Taguchi T; Hieda Y; Higashiyama S
J Cell Biol; 2008 Feb; 180(4):763-9. PubMed ID: 18299347
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
Ozeki K; Tanida S; Morimoto C; Inoue Y; Mizoshita T; Tsukamoto H; Shimura T; Kataoka H; Kamiya T; Nishiwaki E; Ishiguro H; Higashiyama S; Joh T
PLoS One; 2013; 8(2):e56770. PubMed ID: 23451083
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF.
Nanba D; Mammoto A; Hashimoto K; Higashiyama S
J Cell Biol; 2003 Nov; 163(3):489-502. PubMed ID: 14597771
[TBL] [Abstract][Full Text] [Related]
8. Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.
Shimura T; Yoshida M; Fukuda S; Ebi M; Hirata Y; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
BMC Cancer; 2012 May; 12():205. PubMed ID: 22646534
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor.
Wang X; Mizushima H; Adachi S; Ohishi M; Iwamoto R; Mekada E
Cell Struct Funct; 2006; 31(1):15-27. PubMed ID: 16557002
[TBL] [Abstract][Full Text] [Related]
10. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
[TBL] [Abstract][Full Text] [Related]
11. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells.
Wang F; Sloss C; Zhang X; Lee SW; Cusack JC
Cancer Res; 2007 Sep; 67(18):8486-93. PubMed ID: 17875687
[TBL] [Abstract][Full Text] [Related]
12. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
Umata T; Hirata M; Takahashi T; Ryu F; Shida S; Takahashi Y; Tsuneoka M; Miura Y; Masuda M; Horiguchi Y; Mekada E
J Biol Chem; 2001 Aug; 276(32):30475-82. PubMed ID: 11402047
[TBL] [Abstract][Full Text] [Related]
13. The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades.
Takenobu H; Yamazaki A; Hirata M; Umata T; Mekada E
J Biol Chem; 2003 May; 278(19):17255-62. PubMed ID: 12611888
[TBL] [Abstract][Full Text] [Related]
14. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface.
Chen X; Raab G; Deutsch U; Zhang J; Ezzell RM; Klagsbrun M
J Biol Chem; 1995 Aug; 270(31):18285-94. PubMed ID: 7629148
[TBL] [Abstract][Full Text] [Related]
15. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
[TBL] [Abstract][Full Text] [Related]
16. Amino-terminal deletion of heparin-binding epidermal growth factor-like growth factor4-127 stimulates cell proliferation but lacks insulin-like activity.
Zhou Z; Harding PA
Cell Prolif; 2007 Apr; 40(2):213-30. PubMed ID: 17472728
[TBL] [Abstract][Full Text] [Related]
17. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor.
Mehta VB; Besner GE
J Immunol; 2003 Dec; 171(11):6014-22. PubMed ID: 14634113
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
20. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.
Fernández de Mattos S; Essafi A; Soeiro I; Pietersen AM; Birkenkamp KU; Edwards CS; Martino A; Nelson BH; Francis JM; Jones MC; Brosens JJ; Coffer PJ; Lam EW
Mol Cell Biol; 2004 Nov; 24(22):10058-71. PubMed ID: 15509806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
